|
Index of reports
> Cases resulting in death (20)
Below is the selection of adverse event reports related to Noxafil (Posaconazole) that includes cases resulting in death.
Adverse event in 74 year old male receiving Noxafil (Posaconazole)
Reported by a individual with unspecified qualification from Spain on 2007-07-25
Patient: 74 year old male
Adverse reactions / side effects: Nasopharyngitis, Drug Ineffective, Pseudomonas Infection, Drug Interaction, General Physical Health Deterioration, Septic Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Carduran NEO (Con.); Urbal (Con.); Amchafibrin (Con.); Aprovel (Con.); Seguril (Con.); Vitamin K (Con.); Duphalac (Con.); Aldactone (Con.); Finasteride (Con.); Targocid (Con.); Zyloric (Con.); Fluidasa (Con.); Albumin (Con.); Folic Acid (Con.); Danatrol (Prev.); Proscar (Prev.); Carduran NEO (Prev.); Dilutol (Prev.); Acovil (Prev.); Zyloric (Prev.); Voriconazole (Con.); Caspofungin (Con.)
Adverse event in 80 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-07-13
Patient: 80 year old female
Adverse reactions / side effects: Intestinal Ischaemia, Intestinal Perforation, Peritonitis
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Novalgin; Vancomycin; Clont; Paspertin; Konakion; Lasix; Aspirin; Beloc ZOK; Acyclovir; Sufentanil Citrate; Pantozol; Human Insulin; Heparin; Clonidine HCL; Propofol; Meronem; Movicol
Adverse event in 68 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-07-06
Patient: 68 year old female
Adverse reactions / side effects: Hypovolaemic Shock, Haemoptysis, Coagulopathy, Disseminated Intravascular Coagulation, Pulmonary Embolism, Hepatocellular Damage, Haemodialysis, Multi-Organ Failure, Capillary Leak Syndrome, Hepatotoxicity, Acute Hepatic Failure, Diffuse Alveolar Damage
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Levofloxacin; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Cytarabine; Etoposide; Melphalan; Palifermin; Ambisome; Cancidas; Diflucan; Vfend; Acyclovir; Clexane
Adverse event in female receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-06-19
Patient: female, weighing 48.1 kg (105.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Hypovolaemic Shock, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, B-Cell Lymphoma Stage III, Metabolic Disorder, Lung Injury, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Endometriosis, Osteoporosis, Chills, Salpingo-Oophorectomy, Somnolence, Polyneuropathy, Chest X-RAY Abnormal, Stem Cell Transplant, Capillary Leak Syndrome, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Antithrombin III Decreased, Thrombocytopenia, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Renal Failure, Diarrhoea, Cardiac Failure, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Noxafil
Dosage: unk, unk
Start date: 2006-12-15
End date: 2006-12-20
Other drugs received by patient: Cytarabine; Cytarabine; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic
Adverse event in male receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-05-31
Patient: male
Adverse reactions / side effects: Pneumonia, Treatment Noncompliance, Septic Shock
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-05-15
Patient: female, weighing 48.1 kg (105.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Pruritus, Disseminated Intravascular Coagulation, Prothrombin Time Prolonged, Pyrexia, Chemotherapy, B-Cell Lymphoma Stage III, Metabolic Disorder, Bronchopulmonary Aspergillosis, Pneumonia, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Haemolysis, Fungal Infection, Aspartate Aminotransferase Increased, Disturbance in Attention, Colon Polypectomy, Hypersensitivity, Osteoporosis, Endometriosis, Chills, Salpingo-Oophorectomy, Somnolence, Chest X-RAY Abnormal, Polyneuropathy, Stem Cell Transplant, Fatigue, Gamma-Glutamyltransferase Increased, Thyroidectomy, Liver Function Test Abnormal, Pleural Effusion, Thrombocytopenia, Antithrombin III Decreased, Haptoglobin Decreased, Haemoptysis, Laparoscopic Sterilisation, Rash, Varicose Vein, T-Cell Lymphoma Stage III, Osteoarthritis, Diarrhoea, Sepsis, Acute Hepatic Failure, Asthenia, Venous Stent Insertion, Infection
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Tegretol
Dosage: 200 mg/day
Administration route: Oral
Noxafil
Dosage: unk, unk
Start date: 2006-12-15
End date: 2006-12-20
Other drugs received by patient: Arac; Arac; Rituximab; Cisplatin; Dexamethasone 0.5mg TAB; Carmustine; Etoposide; Melphalan; Liskantin; Kalinor Retard; Ambisome; Ambisome; Ambisome; Ambisome; Cancidas; Cancidas; Cancidas; Diflucan; Vfend; Acyclovir; Clexane; Palifermin; Palifermin; Tavanic
Adverse event in 40 year old female receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-11
Patient: 40 year old female
Adverse reactions / side effects: Renal Cell Carcinoma Stage Unspecified, Cardiac Arrest
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-05-07
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Pneumonia Bacterial, Respiratory Arrest, Acute Respiratory Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole (Prev.); Prograft (Con.); Sulfadiazine (Con.); Medrol / 00049601 / (Con.); Meronem / 01250501 / (Con.)
Adverse event in 40 year old female receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-30
Patient: 40 year old female
Adverse reactions / side effects: Renal Cell Carcinoma Stage Unspecified, Cardiac Arrest
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-04-23
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Pneumonia Fungal, Pneumonia Bacterial, Respiratory Arrest, Condition Aggravated, Acute Respiratory Failure
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole; Prograf; Sulfadiazine; Medrol; Meronem / 01250501 /
Adverse event in male receiving Noxafil (Posaconazole)
Reported by a individual with unspecified qualification from Spain on 2007-04-23
Patient: male
Adverse reactions / side effects: Pseudomonas Infection, Drug Interaction
Adverse event resulted in: death
Suspect drug(s):
Noxafil
Indication: Drug USE FOR Unknown Indication
Gastric Protector NOS (Drugs FOR Functional Gastrointest. Disorders)
Indication: Gastric Disorder
Adverse event in male receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-19
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in receiving Noxafil (Posaconazole)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-04-09
Patient:
Adverse reactions / side effects: Pseudomonas Infection, Drug Interaction
Adverse event resulted in: death
Suspect drug(s):
Noxafil
Indication: Drug USE FOR Unknown Indication
Gastric Protector NOS (NO Pref. Name)
Indication: Gastric Disorder
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-04-09
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Pneumonia Fungal, Respiratory Failure, Pneumonia Bacterial, Respiratory Arrest, Carbon Dioxide Increased, Lung Abscess, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole (Prev.); Prograft (Con.); Sulfadiazine (Con.)
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-04-04
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Respiratory Failure, Pneumonia Bacterial, Respiratory Arrest
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole; Prograf; Sulfadiazine
Adverse event in 38 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Belgium on 2007-03-27
Patient: 38 year old female, weighing 34.0 kg (74.8 pounds)
Adverse reactions / side effects: Pneumonia, Respiratory Failure, Respiratory Arrest, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Posaconazole (Prev.)
Adverse event in 68 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-03-12
Patient: 68 year old female
Adverse reactions / side effects: Drug Toxicity, Haemoptysis, Disseminated Intravascular Coagulation, Acute Hepatic Failure, Hepatocellular Damage, Haemolysis, Haemodialysis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
Other drugs received by patient: Tavanic; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Arac; Etoposide; Melphalan; Palifermin; Ambisome; Diflucan; Vfend; Acyclovir; Clexane
Adverse event in 68 year old female receiving Noxafil (Posaconazole)
Reported by a physician from Germany on 2007-02-23
Patient: 68 year old female
Adverse reactions / side effects: Acute Hepatic Failure, Haemodialysis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Noxafil
Dosage: 800 mg;qd;po
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-12-15
End date: 2006-12-22
Noxafil
Dosage: 800 mg;qd;po
Administration route: Oral
Indication: Prophylaxis
Start date: 2006-12-15
End date: 2006-12-22
Other drugs received by patient: Tavanic; Tegretol; Liskantin; Magno Sanol; Kalinor RET; Carmustine; Arac; Etoposide; Melphalan; Paliformin; Ambisome; Cancidas; Diflucan; Vfend; Acyclovir; Clexane
Adverse event in 65 year old male receiving Noxafil (Posaconazole)
Reported by a physician from United States on 2007-01-22
Patient: 65 year old male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Noxafil (Posaconazole)
Adverse event in female receiving Noxafil (Posaconazole)
Reported by a physician from Portugal on 2007-01-17
Patient: female
Adverse reactions / side effects: NO Adverse Drug Effect
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Noxafil (Posaconazole)
|
